BIOMAT Database Logo BIOMAT Database Logo

Retrieval of crystalloid cardioplegic solutions. 1996

P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
Department of Cardiovascular Surgery, University Hospital of Mont-Godinne, Yvoir, Belgium.

UI MeSH Term Description Entries
D002314 Cardioplegic Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. Cardioplegic Solution,Solution, Cardioplegic,Solutions, Cardioplegic
D006324 Heart Arrest, Induced A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate). Cardiac Arrest, Induced,Cardioplegia,Induced Cardiac Arrest,Induced Heart Arrest,Cardioplegias
D006438 Hemodilution Reduction of blood viscosity usually by the addition of cell free solutions. Used clinically (1) in states of impaired microcirculation, (2) for replacement of intraoperative blood loss without homologous blood transfusion, and (3) in cardiopulmonary bypass and hypothermia. Hemodilutions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
February 1988, The Journal of thoracic and cardiovascular surgery,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
Effect of pH shifts induced by oxygenating crystalloid cardioplegic solutions.
October 1991, The Annals of thoracic surgery,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
[Evaluation of myocardial protection with DBcAMP in crystalloid cardioplegic solutions].
December 1989, Rinsho kyobu geka = Japanese annals of thoracic surgery,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
Comparison of crystalloid and sanguineous cardioplegic solutions in the dog.
June 1985, American journal of veterinary research,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
Resistance differences between blood and crystalloid cardioplegic solutions with myocardial cooling.
April 1981, The Journal of surgical research,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
[Clinical evaluation of myocardial protection by oxygenated crystalloid cardioplegic solutions with DBcAMP].
June 1992, Nihon Geka Gakkai zasshi,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
The effects of two different crystalloid cardioplegic solutions on cultured human endothelial cells.
January 1989, The Journal of cardiovascular surgery,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
Effects of crystalloid and blood cardioplegic solutions on myocardial cooling during myocardial revascularization.
May 1984, Canadian journal of surgery. Journal canadien de chirurgie,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients.
May 1984, Circulation,
P M Eucher, and M Buche, and S Broka, and J C Schoevaerdts
[Early and late damage in bypass vessels induced by crystalloid and cardioplegic solutions].
January 1991, VASA. Supplementum,
Copied contents to your clipboard!